Filing Details

Accession Number:
0000899243-21-025074
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-21 18:25:41
Reporting Period:
2021-06-17
Accepted Time:
2021-06-21 18:25:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1840574 Verve Therapeutics Inc. VERV Pharmaceutical Preparations (2834) 824800132
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1864505 Margaret Beaudoin C/O Verve Therapeutics, Inc.
500 Technology Square, Suite 901
Cambridge MA 02139
Vice President, Finance No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-06-21 1,000 $19.00 1,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2021-06-17 10,799 $0.00 10,799 $19.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,799 2031-06-16 No 4 A Direct
Footnotes
  1. The option was granted on June 17, 2021. 25% of the shares underlying the option will vest on June 1, 2022, and the remainder are scheduled to vest in equal monthly installments thereafter until June 1, 2025.